AstraZenecas

A 32-year-old psychologist in Britain developed blood clots and died 10 days after he took his first dose of AstraZeneca’s Covid vaccine, a report released by a London coroner on Wednesday…

LONDON (AP) — The European Union's drug regulator said…

A separate Phase IV trial reported in a preprint with The Lancet showed that a third dose of Vaxzevria substantially increased antibody levels following a primary vaccine series with…

While the Omicron variant was not in circulation during the Evusheld clinical trials, the company added that it is continuing to collect further data to better understand the implications…

LONDON— AstraZeneca AZN -0.76% PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across…

The deal represents a hike from a long-term supply agreement valued at $331 million signed between the two firms in September. Evusheld is an injectable…

When Pascal Soriot unveiled AstraZeneca’s new vaccine strategy he could scarcely hide his exasperation. After thrusting his company into the frontline of the battle against Covid by…

London, November 19 A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent capable…

AstraZeneca says its cocktail of antibodies, AZD7442, has given results deemed positive against Covid-19 during phase III clinical trials.Gerard Bottino | SOPA Images | LightRocket | Getty…

It means the body can continue making these vital cells long after the antibodies have waned, as possibly for the rest of your life, it said. Scientists from Oxford, the UK, and…